1. Home
  2. TXMD vs VVOS Comparison

TXMD vs VVOS Comparison

Compare TXMD & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$1.66

Market Cap

21.3M

Sector

Health Care

ML Signal

HOLD

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$2.01

Market Cap

17.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXMD
VVOS
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.3M
17.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
TXMD
VVOS
Price
$1.66
$2.01
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.25
AVG Volume (30 Days)
55.3K
119.1K
Earning Date
11-12-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$2,796,000.00
$17,317,000.00
Revenue This Year
$427.09
$17.96
Revenue Next Year
N/A
$55.64
P/E Ratio
$275.53
N/A
Revenue Growth
75.19
18.76
52 Week Low
$0.70
$1.93
52 Week High
$2.44
$7.95

Technical Indicators

Market Signals
Indicator
TXMD
VVOS
Relative Strength Index (RSI) 50.93 40.08
Support Level $1.64 $1.93
Resistance Level $1.78 $2.07
Average True Range (ATR) 0.14 0.10
MACD -0.02 0.02
Stochastic Oscillator 12.55 28.17

Price Performance

Historical Comparison
TXMD
VVOS

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: